|
[1] D.H. Lewis, Controlled Release of Bioactive Agents from Lactide / Glycolide polymers. In: M. Chain., R. Langer, Biodegradable polymers as Drug Delivery Systems, Marcol Dekker, Inc., New York, 1990, 1-45 [2] A. M. DeCampos , A. Sanchez , R. Gref , P. Calvo , M. J. Alonso. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. European Journal of Pharmaceutical Sciences 20: 73–81 2003. [3] L. Zhanga, Y. Hu, X. Jiang, C. Yang, W. Lu, Y. H. Yang, Camptothecin derivative-loaded poly(caprolactone -co-lactide)-b -PEG-b-poly(capro- lactone-co-lactide) nanoparticles and their biodistribution in mice, Journal of controlled release, 96, 135-148, 2004. [4].Kurita, K.; Chemistry and application of chitin and chitosan, Polymer Degradation and Stability, 59, 1998, 117-120. [5].Rachel, C. K.; Ilan C.; The molecular biology of chitin digestion, Current Opinion in Biotechnology, 9, 1998, 270-277. [6] L. Illum, Chitosan and its use as a pharmaceutical excipient, Pharm. Res., 15 (9), 1326-1331, 1998 [7].Majeti N.V.; Kumar, R.; A review of chitin and chitosan applications, Reactive & Functional Polymers, 46, 2000, 1–27. [8].Rhoades, J. and Roller, S.; Antimicrobial actions of degraded and native chitosan against spoilage organisms in laboratory media and foods. Applied Environmental Microbiology, 2000, 66, 80-86. [9].Kuen, Y. L.; Wan, S. H.; Won, H. P.; Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials, 2001, 22, 261-268. [10].Miyazaki, S.; Ishii, K.; Nadai, T.; The use of chitin and chitosan as drug carriers. Chem. Pharm. Bull, 1981, 29, 3067-3069. [11].Aiedeh, K.; Gianasi, E.; Orienti, I.; Zecchi, V.; Chitosan microcapsules as controlled release system for insulin. J. Microencapsul, 1997, 14, 567-576. [12].Giunchedi, P.; Genta, I.; Conti, B..; Muzzarelli, R. AA.; Conte, U.; Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres. Biomaterials 1989, 19, 157-161. [13] K. A. Janes, M. P. Fresneau, A. MaraZuela, A. Fabra, M. J. Alonso, Chitosan nanoparticle as delivery system for Doxorubicin, Journal of controlled release, 73, 255-267,2001 [14].S. H. Chiou.; W. T. Wu.; Y. Y. Huang.; T. W. Chung.; effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres, J. Mocroencapsul. 2001,18, 613-625. [15] M. N. V. Ravi Kumar, U. Bakowsky, C. M. Lehr, Preparation and characterization of cationic PLGA nanospheres as DNA carriers, Biomaterials, 25, 1771-1777, 2004 [16] J. Panyam, V. Lathasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue.,Advanced Drug Delivery Reviews,55,329-347, 2003 [17] J.G. Shiah, M. Dvorak, P. Kopecekova, Y. Sun, C.M. Peterson, J. Kopecek, Biodistribution and antitumour efficacy of long-circulation N-(2-hydorxypropyl)methacrylamide co- polymer-doxorubicin conjugates in nude mice, Eur. J. Cancer 37:131-139,2001 [18] S. M. Moghimi, A. C. Hunter, J. C. Murry, Long-circnlating and target specific nanoparticles: theory to practice, Pharmacol. Rev. 53(2), 283-318, 2001 [19] C. Rouzes, R. Gref, MLeonard, A. De Sousa Delgado, E. Dellacheride, Surface modification of poly(lactic acid) nanospheres using hydophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique, J. Biomed. Mater. Res. 50:557-565 2000. [20] R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, R.H. Muller, Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids and Surfaces B: Biointerfaces, 18, 301–313, 2000 [21] A. Vila, A. Sanchez, M. Tobio, P. Calvo, M.J. Alonso, Design of biodegradable particle for protein delivery, Journal of controlled release, 78: 15-24, 2002 [22] S. Faraasen, J. Voros, G. Csucs, M. Textor, H. P. Merkle, and E. Walter, Ligand –Specific Targeting of Microspheres to Phagocytes by Surface Modification with Poly(L-Lysine)-Grafted Ply(Ethylene Glycol) Conjugate, Pharmaceutical Research, Vol. 20, 2, 237-246, 2003 [23] J. Panyam, V. Lathasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue.,Advanced Drug Delivery Reviews,55,329-347, 2003 [24]Lemarchand, Caroline, Gref, Ruxandra, Couvreur, Patrick. Polysaccharide-decorated nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics,58.327-341. 2004 [25].Lavasanifar, A.; Samuel, J.; Kwon, G. S.; Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery, Advanced Drug Delivery Reviews, 54, 2002, 169-190. [26].Wang, Z. I.; Liu, Y.; Zhang, Z.; “Handbook of Nanophase and Nanostructured Materials Volume I:Synthesis”, Kluwer Academic/Plenum Publishers, 2002, 1-3. [27].Yoo, H. S.; Lee, E. A.; Park, T. G.; Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages, Journal of Controlled Release, 82, 2002, 17-27. [28].Pierschbacher M. D.; and Ruoslahti, E.; Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule., Nature, 309, 1984, 30-33. [29].Anselme, K.; Osteoblast adhesion on biomaterials., Biomaterials, 21, 2000, 667-681. [30].Chen, X.; Park, R.; Shahinian, A. H.; Bading, J. R.; Conti, P. S.; Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation, Nuclear Medicine and Biology 31 ,2004, 11-19. [31].Chen, X.; Park, R.; Shahinian, A. H.; Tohme, M.; Khankaldyyan, V.; Bozorgzadeh, M. H.; Bading, J. R.; Moats, R.; Laug, W. E.; Conti, P. S.; 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis, Nuclear Medicine and Biology 31, 2004, 179-189. [32].Laboratory Investigation Vol 81, No.4, 439~452 (2001) [33]J. M. Saul , A. Annapragada , J. V. Natarajan ,a , R. V. Bellamkonda. C ontrolled targeting of liposomal doxorubicin via the folate receptor in vitro . Journal of Controlled Release 92:49–67 ,2003. [34]H. S. Yoo, T. G. Park. Folate receptor targeted bio- degradable polymeric doxorubicin micelles. Journal of Controlled Release 96:273–283,2004. [35] G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, G. Giammona, Amoxicillin-loaded polyethylcyano -acrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials, 22, 2857-2865, 2001 [36] A. Bigi, G. Cojazzi, S. Panzavolta, K. Rubini. Stabilization of gelatin films by crosslinking with genipin. Biomaterials, 23, 4827-4832, 2002. [37] H.W. Sung, R.N. Huang, L.L.H. Huang, C.C. Tsai, C.T. Chiu. Feasibility study of a natural crosslinking reagent for biological tissue fixation. J. Biomed. Mater. Res., 42, 560-567, 1998. [38] H.W. Sung, D.M. Huang, W.H. Chang, R.N. Huang, J.C. Hsu. Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: In vitro study. J. Biomed. Mater.Res., 46, 520-530, 1999. [39].Mi, F. L.; Tan, Y. C.; Liang, H. F.; Sung, H. W.; In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant, Biomaterials, 23, 2002, 181-191. [40].Mi, F. L.; Sung, H. W.; Shyu, S. S.; Su, C. C.; Peng, C. K.; Synthesis and characterization of biodegradable TPP/genipin cocrosslinked chitosan gel beads, Polymer, 44, 2003, 6521-6530. [41].Kurita, K.; Tomita, J.; Tada, T.; Nishimura, S. L.; lshii, S.; Reactivity characteristics of a new form of chitosan, Polymer Bulletin, 30, 1993, 429-433. [42].Jin, K. K.; Park, D. J.; Lee, M.S.; Kyo, J. I. Synthesis and crystallization benavior of Poly(L-lactide)-block-Poly(ε-caprolactone) copolymer, Polymer, 42, 2001, 7429-7441. [43].Brown, W. H. H.; Benson, D. R.; Iverson, B.; Iverson, S.; Introduction to Organic Chemistry, 2nd Edition, Harcourt College Publishers, 1999. [44].Pavia, D. L.; Lampman, g. M.; Kriz, G. S.; Introduction to Spectroscopy, Saunders College Publishing, 1996. [45].Skoog D. A.; and Leary, J. J.; Principles of Instrumental Analysis" 4th Edition, Saunders College Publishing, New York, 1992. [46].Christine, A.; Dusica M.; Adi, E.; Nano-engineering block copolymer aggregates for drug delivery, Colloids and Surfaces B: Biointerfaces, 16, 1999, 3-27. [47].Jeong, B.; Kibbey, M. R.; Birnbaum, J. C.; Won, Y. Y.; Gutowska, A.; Thermogelling Biodegradable Polymers with Hydrophilic Backbones:PEG-g-PLGA, Macromolecules, 33, 2000, 8317-8322. [48].Jeong, B.; Kibbey, M. R.; Birnbaum, J. C.; Won, Y. Y.; Gutowska, A.; Thermogelling Biodegradable Polymers with Hydrophilic Backbones:PEG-g-PLGA, Macromolecules, 33, 2000, 8317-8322. [49].Taillefef, J.; Jones, M.C.; Nrasseur, N.; Van lier, J.E.; Leroux, J.C.; Preparation and characterization of PH-responsive polymer micelles for the delivery of photosensitizing anticancer drugs, Journal of pharmaceutical sciences, 89, 2000, 52-62. [50]Mi, F. L., Tan, Y. C., Liang, H. F., & Sung, H. W. (2002). In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials, 23, 181-191. [51]Mi, F. L., Sung, H. W., Shyu, S. S., Su, C. C., & Peng, C. K. (2003). Synthesis and characterization of biodegradable TPP/genepin co-crosslinked chitosan gel beads. Polymer, 44, 6521 - 6530. [52]Ouchi, T., Miyazaki, H., Arimura, H., Tasaka, F., Hamada, A., & Ohya, Y. (2002). Formation of polymeric micelles with amino surfaces from amphiphilic AB-type diblock copolymers composed of poly(glycolic acid lysine) segments and polylactide segments. J. polym. sci. A Polym. Chem., 40, 1426 - 1432. [52]Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2004). Development of Solid Lipid Nanoparticles Containing Ionically Complexed Chemotherapeutic Drugs and Chemosensitizers. J. pharm. Sci., 93, 1993 - 2008 [53]Shuai, X., Ai, H., Nasongkla, N., Kim, S., & Gao, J. (2004). Micellar carriers based on block copolymers of poly (ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release, 98, 415 - 426. [54] T. –W. Chunga, Y. –F. Luc, S. –S. Wangc, Y. –S. Lin, S. –H. Chuc, Growth of human endothelial cells on photochemically grafted Gly–Arg–Gly–Asp (GRGD) chitosans, Biomaterials, 23, 4803-4809, 2002 [55] T.W. Chung, Y.F. Lu, S.S. Wang, S.H. Chu, “Growth of human endothelial cells on photochemically grafted Gly-Arg-Gly-Asp (GRGD) on chitosans”, (Biomaterials, 2002, Vol. 23, 4803-4809) [56].Kurita, K.; Tomita, J.; Tada, T.; Nishimura, S. I.; lshii, S.; Reactivity characteristics of a new form of chitosan, Polymer Bulletin, 30, 1993, 429-433. [57].Harish Prashanth, K. V.; Kittur, F. S.; Tharanathan, R. N, Solid state structure of chitosan prepared under different N-deacetylating conditions, Carbohydrate Polymers, 50, 2002, 27-33. [58].Brugnerotto, J.; Lizardi, J.; Goycoole, F. M.; Arguelles-Monal, W.; Desbrie¡res, J.; Rinaudo, M.; An infrared investigation in relation with chitin and chitosan characterization, Polymer , 42, 2001, 3569-3580. [59].Can, Z.; Qineng, P.; Hongjuan, Z.; Jian, S.; Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol, 54, 2003, 137-141. [60].Felgner, P. L.; and Ringold, G. M.; Cationic liposome-mediated transfection. Nature, 1989, 337, 387-388. [61].Kurita, K.; Tomita, J.; Tada, T.; Nishimura, S. I.; lshii, S.; Reactivity characteristics of a new form of chitosan, Polymer Bulletin, 30, 1993, 429-433. [62].Ken, T.; Hiroshi, O.; Mayumi, O. K.; Kiyoshi, H.; Yutaka, M.; Deacetylation of chitin oligosaccharides of dp 2-4 by chitin deacetylase from Colletotrichum lindemuthianum, Carbohydrate Research, 303, 1997, 353-358. [63].Kim, J. Y.; Lee, J. K.; Lee, T. S.; Park, W. H.; Synthesis of chitooligosaccharide derivative with quaternary ammonium group and its antimicrobial activity against Streptococcus mutans, International Journal of Biological Macromolecules, 32, 2003, 23-27. [64].Kurita, K.; Tomita, J.; Tada, T.; Nishimura, S. L.; lshii, S.; Reactivity characteristics of a new form of chitosan, Polymer Bulletin, 30, 1993, 429-433. [65].Jeong, B.; Bae, Y. H.; Kim, S. W.; Biodegradable thermosensitive micelles of PEG-PLGA-PEG triblock copolymers, Colloid Surface B. 1999, 16, 185-193. [66] Jeong, B.; Kibbey, M. R.; Birnbaum, J. C.; Won, Y. Y.; Gutowska, A. Macromolecules 2000, 33, 8317-22. [67] Savic, R.; Luo, L.; Eisenberg, A.; Maysinger, D. Science 2003, 300, 615-618. [68] Chang, Y.; Prange, R.; Allcock, H. R.; Lee, S. C.; Kim, C. Macromolecules 2002, 35, 8556-8559. [69] T. Govender, T. Riley, T. Ehtezazi, M. C. Garnett, S. Stolnik, L. Illum, Stanley S. Davis, Defining the drug incorporation properties of PLA–PEG nanoparticles, International journal of pharmaceutics, 199, 95-110, 2000 [70] M. N. V. Ravi Kumar, U. Bakowsky, C. M. Lehr, Preparation and characterization of cationic PLGA nanospheres as DNA carriers, Biomaterials, 25, 1771-1777, 2004 [71]Shuai, X., Ai, H., Nasongkla, N., Kim, S., & Gao, J. (2004). Micellar carriers based on block copolymers of poly (ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release, 98, 415 - 426. [72]Yoo, H. S., & Park, T. G. (2004). Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release, 70 , 63 - 70. [73].Torchilin, V. P., Structure and design of polymeric surfactant-based drug delivery systems, J. Controlled. Release, 73, 2001, 137-172. [74].Anselme, K.; Osteoblast adhesion on biomaterials., Biomaterials, 21, 2000, 667-681. [75].Jeong, B.; Bae, Y. H.; Kim, S. W.; Biodegradable thermosensitive micelles of PEG-PLGA-PEG triblock copolymers, Colloid Surface B. 1999, 16, 185-193. [76].Park Y. J.; Lee, J. Y.; Chang, Y. S.; Jeong, J. M.; Chung, J. K.; Lee, M. C.; Park, K. B.; Lee, S. J.; Radioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imaging, Biomaterials 2002, 23, 873-879. [77].Lee, S. C.; Chang, Y.; Yoon, J.-S.; Kim, C.; Kwon, I. C.; Kim, Y.-H.; Jeong, S. Y.; Synthesis and micellar characterization of amphiphilic diblock copolymers based on poly(2-oxazoline) and aliphatic polyesters, Macromolecules 1999, 32, 1847-1852.
|